Jounce Therapeutics, Inc

(NASDAQ:JNCE)

Latest On Jounce Therapeutics, Inc (JNCE):

Date/Time Type Description Signal Details
2023-04-19 00:22 ESTNewsJounce Acquisition: Exploring Whether It Is Worth It To Pay Up For CVR ValueN/A
2023-03-27 16:54 ESTNewsJounce jumps 23% as Concentra agrees to acquire for $1.85 per share cashN/A
2023-03-15 13:01 ESTNewsJounce stock jumps after confirming acquisition bid from Concentra BiosciencesN/A
2023-02-23 16:19 ESTNewsJounce stock soars ~35% on all-stock merger with Redx PharmaN/A
2023-02-23 16:18 ESTNewsJounce Therapeutics downgraded to market perform at Raymond James on company restructuringN/A
2023-02-23 03:10 ESTNewsJounce Therapeutics to restructure, lay off more than half of workforce; stock jumps 15%N/A
2022-12-29 19:40 ESTNewsJounce: Gilead's GS-1811 Buyout Allows A Further BounceN/A
2022-12-27 23:33 ESTNewsJounce soars 59% after Gilead will acquire remaining rights to cancer immunotherapyN/A
2022-11-11 12:12 ESTNewsJounce downgraded to outperform at Raymond James on timing for data on immunotherapyN/A
2022-11-10 18:52 ESTNewsJounce Therapeutics GAAP EPS of -$0.60 beats by $0.04; reaffirms FY22 guidanceN/A
2022-11-10 18:51 ESTNewsJounce Therapeutics, Inc. (JNCE) Q3 2022 Results - Earnings Call TranscriptN/A
2022-11-10 01:57 ESTNewsJounce Therapeutics Q3 2022 Earnings PreviewN/A
2022-11-02 19:11 ESTNewsJounce jumps on $15M milestone from Gilead under cancer drug development pactN/A
2022-08-30 22:49 ESTNewsJounce drops ~29% as lung cancer therapy fails in mid-stage trialN/A
2022-08-05 20:00 ESTNewsJounce Therapeutics, Inc. (JNCE) CEO Richard Murray on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-04 12:54 ESTNewsJounce Therapeutics GAAP EPS of -$0.65 beats by $0.04N/A
2022-05-12 01:05 ESTNewsJounce Therapeutics slides after Baird pulls bullish view on JTX-8064 concernsN/A
2022-05-07 23:59 ESTNewsJounce Therapeutics, Inc. (JNCE) CEO Richard Murray on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-07 03:53 ESTNewsJounce upgraded to Strong Buy at Raymond James after pipeline updatesN/A
2022-05-06 04:22 ESTNewsJounce Therapeutics GAAP EPS of -$0.72 misses by $0.15N/A
2022-05-05 05:13 ESTNewsJounce Therapeutics Q1 2022 Earnings PreviewN/A
2022-03-02 19:13 ESTNewsJounce Therapeutics GAAP EPS of -$0.59 misses by $0.27N/A
2022-03-02 19:13 ESTNewsJounce Therapeutics, Inc. 2021 Q4 - Results - Earnings Call PresentationN/A
2022-03-02 19:12 ESTNewsJounce Therapeutics, Inc. (JNCE) CEO Richard Murray On Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-02 02:47 ESTNewsJounce Therapeutics Q4 2021 Earnings PreviewN/A
2022-01-15 16:54 ESTNewsJounce Therapeutics (JNCE) Investor Presentation - SlideshowN/A
2021-12-17 05:25 ESTNewsJounce Therapeutics: A Favorable Risk-Reward Ahead Of Critical 2022 CatalystsN/A
2021-11-04 11:26 ESTNewsJounce Therapeutics EPS misses by $0.15N/A
2021-11-04 11:25 ESTNewsJounce Therapeutics, Inc's. (JNCE) CEO Richard Murray On Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-03 14:18 ESTNewsJounce Therapeutics Q3 2021 Earnings PreviewN/A
2021-09-10 23:33 ESTNewsJounce Therapeutics (JNCE) Corporate PresentationN/A
2021-08-06 05:31 ESTNewsJounce Therapeutics EPS beats by $0.28, beats on revenueN/A
2021-08-06 05:26 ESTNewsJounce Therapeutics, Inc. 2021 Q2 - Results - Earnings Call PresentationN/A
2021-08-06 05:26 ESTNewsJounce Therapeutics, Inc. (JNCE) CEO Rich Murray on Q2 2021 Results - Earnings Call TranscriptN/A
2021-07-21 13:26 ESTNewsJounce shares rise on $25M milestone payment from GileadN/A
2021-07-21 13:07 ESTNewsJounce Therapeutics: An Under The Radar And Undervalued BiotechN/A
2021-05-05 18:27 ESTNewsJounce Therapeutics, Inc. 2021 Q1 - Results - Earnings Call PresentationN/A
2021-05-04 21:59 ESTNewsJounce Therapeutics EPS beats by $0.01, misses on revenueN/A
2021-05-04 21:57 ESTNewsJounce Therapeutics, Inc. (JNCE) CEO Rich Murray on Q1 2021 Results - Earnings Call TranscriptN/A
2021-03-31 03:44 ESTNewsRevisiting Jounce TherapeuticsN/A
2021-03-16 21:12 ESTAnalyst RatingThe Analyst Target Price has increased from $15 to $16.Buy
2021-03-10 14:17 ESTNewsJounce Therapeutics raises $56M via equity offeringN/A
2021-03-09 18:55 ESTNewsJounce Therapeutics launches stock offeringN/A
2021-03-03 00:17 ESTAnalyst RatingThe Analyst Target Price has increased from $12.63 to $15.Buy
2021-03-01 15:48 ESTAnalyst RatingThe Analyst Target Price has increased from $11.63 to $12.63.Neutral
2021-02-28 07:20 ESTNewsJounce Therapeutics, Inc. (JNCE) CEO Rich Murray on Q4 2020 Results - Earnings Call TranscriptN/A
2021-02-28 03:51 ESTFinancialsCompany financials have been released.Neutral
2021-02-26 15:48 ESTFinancialsCompany financials have been released.Neutral
2021-02-26 03:59 ESTEarnings EstimateAn EPS average of -$2.13 is estimated for the 2022 year.Sell
2021-02-26 03:59 ESTEarnings EstimateAn EPS average of -$0.45 is estimated for the quarter ending on June 30, 2021.Sell

About Jounce Therapeutics, Inc (JNCE):

Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid tumors. It is also developing JTX-4014, an anti-PD-1 antibody for combination therapy; JTX-8064, an antibody that binds to leukocyte immunoglobulin like receptor B2, which is a cell surface receptor expressed on macrophages; and JTX-1811, an anti-CCR8 monoclonal antibody designed to selectively deplete intra-tumoral T regulatory cells in the tumor microenvironment. Jounce Therapeutics, Inc. was incorporated in 2012 and is headquartered in Cambridge, Massachusetts.

JNCE Quotes by TradingView

See Advanced Chart

General

  • Name Jounce Therapeutics, Inc
  • Symbol JNCE
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 128
  • Fiscal Year EndDecember
  • IPO Date2017-01-27
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://jouncetx.com
View More

Valuation

  • Trailing PE 11.8
  • Forward PE 28.49
  • Price/Sales (Trailing 12 Mt.) 6.96
  • Price/Book (Most Recent Quarter) 2.63
  • Enterprise Value Revenue 5.88
  • Enterprise Value EBITDA 6.8
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.44
  • Next Year EPS Estimate -$2.10
  • Next Quarter EPS Estimate -$0.44
  • Profit Margin -70%
  • Operating Margin -72%
  • Return on Assets -13%
  • Return on Equity -23%
  • Revenue 62.34 million
  • Earnings Per Share $0.63
  • Revenue Per Share $1.76
  • Gross Profit 25.35 million
  • Quarterly Earnings Growth 722.2%
View More

Highlights

  • Market Capitalization 574.85 million
  • EBITDA 22.6 million
  • Analyst Target Price $16
  • Book Value Per Share $5.06
View More

Share Statistics

  • Shares Outstanding 51.14 million
  • Shares Float 34.3 million
  • % Held by Insiders 2314%
  • % Held by Institutions 63.38%
  • Shares Short 618517
  • Shares Short Prior Month 1.07 million
  • Short Ratio 1.87
  • Short % of Float 2%
  • Short % of Shares Outstanding 1%
View More

Technicals

  • Beta 1.2
  • 52 Week High $14.84
  • 52 Week Low $3.57
  • 50 Day Moving Average 11.95
  • 200 Day Moving Average 9.05
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Jounce Therapeutics, Inc (JNCE) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Jounce Therapeutics, Inc (JNCE) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$N/A$0.86$0.042133.77%
2020-09-302020-11-06$N/A-$0.73-$0.785.88%
2020-06-302020-08-07$N/A-$0.82-$0.72-13.37%
2020-03-312020-05-06$N/A-$0.78-$0.58-34.76%
2019-12-312020-02-27$N/A-$0.68-$0.57-19.3%
2019-09-302019-11-07$119.45 million$2.90$2.2429.73%
2019-06-302019-08-07$17.45 million-$0.21-$0.3437.31%
2019-03-312019-05-08$10.98 million-$0.38-$0.26-44.32%
2018-12-312019-03-06$20.1 million-$0.06-$0.3683.43%
2018-09-302018-11-13$14.53 million-$0.23-$0.3534.23%
2018-06-302018-08-09$19.38 million-$0.14-$0.3761.65%
2018-03-312018-05-09$11.2 million-$0.40-$0.31-27.31%
2017-12-312018-03-08$12.99 million-$0.29-$0.3620.07%
2017-09-302017-11-13$18.08 million-$0.13-$0.2547.85%
2017-06-302017-08-09$20.29 million-$0.11-$0.1526.22%
2017-03-312017-05-09$20.29 million-$0.02-$0.0978%
2016-12-312017-03-10$20.29 million$0.05-$0.01631.91%

Jounce Therapeutics, Inc (JNCE) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Jounce Therapeutics, Inc (JNCE) Chart:

Jounce Therapeutics, Inc (JNCE) News:

Below you will find a list of latest news for Jounce Therapeutics, Inc (JNCE) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Jounce Therapeutics, Inc (JNCE) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest JNCE Trades:

Date Shares Price
Jun 13, 2022 7:58 PM EST131$3.025
Jun 13, 2022 7:58 PM EST69$3.025
Jun 13, 2022 7:58 PM EST100$3.025
Jun 13, 2022 7:59 PM EST31$3.025
Jun 13, 2022 7:59 PM EST51$3.025

Jounce Therapeutics, Inc (JNCE) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000091/0001640455-20-000091-index.htm
2018-03-19UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1640455/000000000018008343/0000000000-18-008343-index.htm
2018-12-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1640455/000031506618002542/0000315066-18-002542-index.htm
2018-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1640455/000090221918000320/0000902219-18-000320-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1640455/000090221919000315/0000902219-19-000315-index.htm
2020-10-26SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1640455/000110465920118184/0001104659-20-118184-index.htm
2020-10-263Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000110465920118186/0001104659-20-118186-index.htm
2018-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1640455/000114420418008872/0001144204-18-008872-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1640455/000114420419008379/0001144204-19-008379-index.htm
2018-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1640455/000119312518042505/0001193125-18-042505-index.htm
2018-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045518000013/0001640455-18-000013-index.htm
2018-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045518000014/0001640455-18-000014-index.htm
2018-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045518000015/0001640455-18-000015-index.htm
2018-03-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045518000022/0001640455-18-000022-index.htm
2018-03-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045518000023/0001640455-18-000023-index.htm
2018-03-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045518000024/0001640455-18-000024-index.htm
2018-03-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1640455/000164045518000028/0001640455-18-000028-index.htm
2018-03-0810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1640455/000164045518000030/0001640455-18-000030-index.htm
2018-03-08S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1640455/000164045518000034/0001640455-18-000034-index.htm
2018-03-08S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1640455/000164045518000035/0001640455-18-000035-index.htm
2018-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045518000039/0001640455-18-000039-index.htm
2018-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045518000040/0001640455-18-000040-index.htm
2018-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045518000041/0001640455-18-000041-index.htm
2018-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045518000043/0001640455-18-000043-index.htm
2018-04-09S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1640455/000164045518000046/0001640455-18-000046-index.htm
2018-04-09CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1640455/000164045518000047/0001640455-18-000047-index.htm
2018-04-27DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1640455/000164045518000053/0001640455-18-000053-index.htm
2018-04-27DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1640455/000164045518000054/0001640455-18-000054-index.htm
2018-04-27CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1640455/000164045518000055/0001640455-18-000055-index.htm
2018-05-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1640455/000164045518000059/0001640455-18-000059-index.htm
2018-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1640455/000164045518000062/0001640455-18-000062-index.htm
2018-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1640455/000164045518000064/0001640455-18-000064-index.htm
2018-06-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1640455/000164045518000068/0001640455-18-000068-index.htm
2018-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045518000070/0001640455-18-000070-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045518000072/0001640455-18-000072-index.htm
2018-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045518000080/0001640455-18-000080-index.htm
2018-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045518000081/0001640455-18-000081-index.htm
2018-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045518000082/0001640455-18-000082-index.htm
2018-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045518000083/0001640455-18-000083-index.htm
2018-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045518000084/0001640455-18-000084-index.htm
2018-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045518000085/0001640455-18-000085-index.htm
2018-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045518000086/0001640455-18-000086-index.htm
2018-06-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1640455/000164045518000089/0001640455-18-000089-index.htm
2018-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1640455/000164045518000093/0001640455-18-000093-index.htm
2018-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1640455/000164045518000095/0001640455-18-000095-index.htm
2018-08-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045518000099/0001640455-18-000099-index.htm
2018-08-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045518000100/0001640455-18-000100-index.htm
2018-08-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045518000101/0001640455-18-000101-index.htm
2018-08-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045518000103/0001640455-18-000103-index.htm
2018-09-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045518000105/0001640455-18-000105-index.htm
2018-11-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1640455/000164045518000109/0001640455-18-000109-index.htm
2018-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1640455/000164045518000111/0001640455-18-000111-index.htm
2018-11-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1640455/000164045518000113/0001640455-18-000113-index.htm
2019-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1640455/000164045519000004/0001640455-19-000004-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045519000009/0001640455-19-000009-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045519000010/0001640455-19-000010-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045519000011/0001640455-19-000011-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045519000012/0001640455-19-000012-index.htm
2019-03-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1640455/000164045519000017/0001640455-19-000017-index.htm
2019-03-0610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1640455/000164045519000021/0001640455-19-000021-index.htm
2019-03-06S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1640455/000164045519000022/0001640455-19-000022-index.htm
2019-04-23DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1640455/000164045519000025/0001640455-19-000025-index.htm
2019-04-23DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1640455/000164045519000026/0001640455-19-000026-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1640455/000164045519000030/0001640455-19-000030-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1640455/000164045519000036/0001640455-19-000036-index.htm
2019-06-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1640455/000164045519000053/0001640455-19-000053-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045519000054/0001640455-19-000054-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045519000055/0001640455-19-000055-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045519000056/0001640455-19-000056-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045519000057/0001640455-19-000057-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045519000058/0001640455-19-000058-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045519000059/0001640455-19-000059-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045519000060/0001640455-19-000060-index.htm
2019-07-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1640455/000164045519000062/0001640455-19-000062-index.htm
2019-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1640455/000164045519000065/0001640455-19-000065-index.htm
2019-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1640455/000164045519000071/0001640455-19-000071-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045519000075/0001640455-19-000075-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045519000076/0001640455-19-000076-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045519000077/0001640455-19-000077-index.htm
2019-09-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1640455/000164045519000081/0001640455-19-000081-index.htm
2019-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1640455/000164045519000084/0001640455-19-000084-index.htm
2019-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1640455/000164045519000087/0001640455-19-000087-index.htm
2019-12-17424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1640455/000164045519000091/0001640455-19-000091-index.htm
2019-12-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1640455/000164045519000093/0001640455-19-000093-index.htm
2019-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045519000095/0001640455-19-000095-index.htm
2020-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000002/0001640455-20-000002-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000003/0001640455-20-000003-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000004/0001640455-20-000004-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000005/0001640455-20-000005-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000006/0001640455-20-000006-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000008/0001640455-20-000008-index.htm
2020-01-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000011/0001640455-20-000011-index.htm
2020-01-233Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000012/0001640455-20-000012-index.htm
2020-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000014/0001640455-20-000014-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000019/0001640455-20-000019-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000020/0001640455-20-000020-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000021/0001640455-20-000021-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000022/0001640455-20-000022-index.htm
2020-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000029/0001640455-20-000029-index.htm
2020-02-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1640455/000164045520000034/0001640455-20-000034-index.htm
2020-02-27S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000035/0001640455-20-000035-index.htm
2020-04-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000037/0001640455-20-000037-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000042/0001640455-20-000042-index.htm
2020-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000043/0001640455-20-000043-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000048/0001640455-20-000048-index.htm
2020-05-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1640455/000164045520000051/0001640455-20-000051-index.htm
2020-06-02DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000054/0001640455-20-000054-index.htm
2020-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000056/0001640455-20-000056-index.htm
2020-06-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000059/0001640455-20-000059-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000068/0001640455-20-000068-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000069/0001640455-20-000069-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000070/0001640455-20-000070-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000071/0001640455-20-000071-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000072/0001640455-20-000072-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000073/0001640455-20-000073-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000074/0001640455-20-000074-index.htm
2020-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000075/0001640455-20-000075-index.htm
2020-07-024/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000084/0001640455-20-000084-index.htm
2020-07-024/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000085/0001640455-20-000085-index.htm
2020-07-024/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000086/0001640455-20-000086-index.htm
2020-07-024/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000087/0001640455-20-000087-index.htm
2020-07-024/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000088/0001640455-20-000088-index.htm
2020-07-024/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000089/0001640455-20-000089-index.htm
2020-07-024/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000090/0001640455-20-000090-index.htm
2020-07-024/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000091/0001640455-20-000091-index.htm
2020-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000100/0001640455-20-000100-index.htm
2020-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1640455/000164045520000103/0001640455-20-000103-index.htm
2020-08-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000107/0001640455-20-000107-index.htm
2020-08-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000108/0001640455-20-000108-index.htm
2020-08-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000109/0001640455-20-000109-index.htm
2020-09-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000112/0001640455-20-000112-index.htm
2020-09-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000114/0001640455-20-000114-index.htm
2020-09-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000116/0001640455-20-000116-index.htm
2020-10-29DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000118/0001640455-20-000118-index.htm
2020-11-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000120/0001640455-20-000120-index.htm
2020-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1640455/000164045520000125/0001640455-20-000125-index.htm
2020-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1640455/000164045520000127/0001640455-20-000127-index.htm
2018-05-01EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1640455/999999999518001058/9999999995-18-001058-index.htm
2020-02-12SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1640455/999999999720000654/9999999997-20-000654-index.htm
2020-03-03SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1640455/999999999720001106/9999999997-20-001106-index.htm

Jounce Therapeutics, Inc (JNCE) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Jounce Therapeutics, Inc (JNCE). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 2314%
Institutional Ownership: 6338%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-03-15Barbara Gayle DuncanDirectorSell2,000.0028.1156,220.000.00https://www.sec.gov/Archives/edgar/data/1640455/000164045518000043/0001640455-18-000043-index.htm
2020-09-15Barbara Gayle DuncanDirectorSell5,000.0010.5052,500.000.00https://www.sec.gov/Archives/edgar/data/1640455/000164045520000116/0001640455-20-000116-index.htm
2018-03-05Elizabeth TrehuChief Medical OfficerSell1,366.0022.1130,202.260.00https://www.sec.gov/Archives/edgar/data/1640455/000164045518000024/0001640455-18-000024-index.htm
2018-03-08Elizabeth TrehuChief Medical OfficerSell4,545.0025.06113,897.700.00https://www.sec.gov/Archives/edgar/data/1640455/000164045518000041/0001640455-18-000041-index.htm
2018-03-08Kimberlee C DrapkinCFO and TreasurerSell5,267.0025.01131,727.670.00https://www.sec.gov/Archives/edgar/data/1640455/000164045518000039/0001640455-18-000039-index.htm
2018-03-05RICHARD /CA/ MURRAYCEO and PresidentSell4,234.0022.0693,402.040.00https://www.sec.gov/Archives/edgar/data/1640455/000164045518000023/0001640455-18-000023-index.htm
2018-03-08RICHARD /CA/ MURRAYCEO and PresidentSell16,334.0025.10409,983.400.00https://www.sec.gov/Archives/edgar/data/1640455/000164045518000040/0001640455-18-000040-index.htm
2020-09-15Barbara Gayle DuncanDirectorBuy10,000.004.2142,100.0010,000.00https://www.sec.gov/Archives/edgar/data/1640455/000164045520000116/0001640455-20-000116-index.htm
2020-01-06John Duncan HiggonsDirectorSell1,500.008.1112,165.0012,013.00https://www.sec.gov/Archives/edgar/data/1640455/000164045520000002/0001640455-20-000002-index.htm
2019-12-23RICHARD /CA/ MURRAYCEO and PresidentBuy40,000.000.4819,200.00134,510.00https://www.sec.gov/Archives/edgar/data/1640455/000164045519000095/0001640455-19-000095-index.htm
2018-03-05Elizabeth TrehuChief Medical OfficerSell3,179.0021.2467,521.961,366.00https://www.sec.gov/Archives/edgar/data/1640455/000164045518000024/0001640455-18-000024-index.htm
2018-08-13Kimberlee C DrapkinCFO and TreasurerBuy14,400.0014,400.00https://www.sec.gov/Archives/edgar/data/1640455/000164045518000099/0001640455-18-000099-index.htm
2018-03-05Kimberlee C DrapkinCFO and TreasurerSell1,267.0022.0727,962.691,508.00https://www.sec.gov/Archives/edgar/data/1640455/000164045518000022/0001640455-18-000022-index.htm
2020-02-03RICHARD /CA/ MURRAYCEO and PresidentBuy75,010.00162,370.00https://www.sec.gov/Archives/edgar/data/1640455/000164045520000020/0001640455-20-000020-index.htm
2018-08-13Hugh M ColeChief Business OfficerBuy14,400.0016,300.00https://www.sec.gov/Archives/edgar/data/1640455/000164045518000100/0001640455-18-000100-index.htm
2018-03-05RICHARD /CA/ MURRAYCEO and PresidentBuy16,334.000.487,840.3216,334.00https://www.sec.gov/Archives/edgar/data/1640455/000164045518000023/0001640455-18-000023-index.htm
2018-03-08RICHARD /CA/ MURRAYCEO and PresidentBuy16,334.000.487,840.3216,334.00https://www.sec.gov/Archives/edgar/data/1640455/000164045518000040/0001640455-18-000040-index.htm
2018-06-15Hugh M ColeChief Business OfficerBuy1,900.007.8414,896.001,900.00https://www.sec.gov/Archives/edgar/data/1640455/000164045518000072/0001640455-18-000072-index.htm
2018-03-15Barbara Gayle DuncanDirectorBuy2,000.004.218,420.002,000.00https://www.sec.gov/Archives/edgar/data/1640455/000164045518000043/0001640455-18-000043-index.htm
2018-06-08Elizabeth TrehuChief Medical OfficerBuy24,875.004.0299,997.5024,875.00https://www.sec.gov/Archives/edgar/data/1640455/000164045518000070/0001640455-18-000070-index.htm
2018-08-27Kimberlee C DrapkinCFO and TreasurerBuy12,700.002.3629,972.0027,100.00https://www.sec.gov/Archives/edgar/data/1640455/000164045518000103/0001640455-18-000103-index.htm
2018-03-05Kimberlee C DrapkinCFO and TreasurerSell4,000.0021.2184,840.002,775.00https://www.sec.gov/Archives/edgar/data/1640455/000164045518000022/0001640455-18-000022-index.htm
2018-09-06RICHARD /CA/ MURRAYCEO and PresidentBuy32,000.000.4815,360.0032,000.00https://www.sec.gov/Archives/edgar/data/1640455/000164045518000105/0001640455-18-000105-index.htm
2020-01-07Hugh M ColeChief Business OfficerSell2,624.007.7820,414.7233,590.00https://www.sec.gov/Archives/edgar/data/1640455/000164045520000003/0001640455-20-000003-index.htm
2019-08-16Hugh M ColeChief Business OfficerSell1,018.003.923,990.5636,214.00https://www.sec.gov/Archives/edgar/data/1640455/000164045519000077/0001640455-19-000077-index.htm
2019-08-15Hugh M ColeChief Business OfficerSell648.004.002,592.0037,232.00https://www.sec.gov/Archives/edgar/data/1640455/000164045519000077/0001640455-19-000077-index.htm
2019-08-14Hugh M ColeChief Business OfficerSell670.004.102,747.0037,880.00https://www.sec.gov/Archives/edgar/data/1640455/000164045519000077/0001640455-19-000077-index.htm
2019-02-01Hugh M ColeChief Business OfficerBuy22,250.0038,550.00https://www.sec.gov/Archives/edgar/data/1640455/000164045519000011/0001640455-19-000011-index.htm
2018-08-13Elizabeth TrehuChief Medical OfficerBuy14,400.0039,275.00https://www.sec.gov/Archives/edgar/data/1640455/000164045518000101/0001640455-18-000101-index.htm
2018-03-05RICHARD /CA/ MURRAYCEO and PresidentSell12,100.0021.21256,641.004,234.00https://www.sec.gov/Archives/edgar/data/1640455/000164045518000023/0001640455-18-000023-index.htm
2020-01-07Kimberlee C DrapkinCFO and TreasurerSell2,624.007.7820,414.7244,390.00https://www.sec.gov/Archives/edgar/data/1640455/000164045520000006/0001640455-20-000006-index.htm
2018-03-05Elizabeth TrehuChief Medical OfficerBuy4,545.004.0218,270.904,545.00https://www.sec.gov/Archives/edgar/data/1640455/000164045518000024/0001640455-18-000024-index.htm
2018-03-08Elizabeth TrehuChief Medical OfficerBuy4,545.004.0218,270.904,545.00https://www.sec.gov/Archives/edgar/data/1640455/000164045518000041/0001640455-18-000041-index.htm
2019-08-16Kimberlee C DrapkinCFO and TreasurerSell1,018.003.923,990.5647,014.00https://www.sec.gov/Archives/edgar/data/1640455/000164045519000075/0001640455-19-000075-index.htm
2019-08-15Kimberlee C DrapkinCFO and TreasurerSell648.004.002,592.0048,032.00https://www.sec.gov/Archives/edgar/data/1640455/000164045519000075/0001640455-19-000075-index.htm
2019-08-14Kimberlee C DrapkinCFO and TreasurerSell670.004.102,747.0048,680.00https://www.sec.gov/Archives/edgar/data/1640455/000164045519000075/0001640455-19-000075-index.htm
2019-02-01Kimberlee C DrapkinCFO and TreasurerBuy22,250.0049,350.00https://www.sec.gov/Archives/edgar/data/1640455/000164045519000010/0001640455-19-000010-index.htm
2020-09-15Barbara Gayle DuncanDirectorSell5,000.009.5047,500.005,000.00https://www.sec.gov/Archives/edgar/data/1640455/000164045520000116/0001640455-20-000116-index.htm
2018-03-08Kimberlee C DrapkinCFO and TreasurerBuy3,759.000.481,804.325,267.00https://www.sec.gov/Archives/edgar/data/1640455/000164045518000039/0001640455-18-000039-index.htm
2020-01-07Elizabeth TrehuChief Medical OfficerSell2,624.007.7820,414.7256,565.00https://www.sec.gov/Archives/edgar/data/1640455/000164045520000005/0001640455-20-000005-index.htm
2019-08-16Elizabeth TrehuChief Medical OfficerSell1,018.003.923,990.5659,189.00https://www.sec.gov/Archives/edgar/data/1640455/000164045519000076/0001640455-19-000076-index.htm
2019-08-15Elizabeth TrehuChief Medical OfficerSell648.004.002,592.0060,207.00https://www.sec.gov/Archives/edgar/data/1640455/000164045519000076/0001640455-19-000076-index.htm
2019-08-14Elizabeth TrehuChief Medical OfficerSell670.004.102,747.0060,855.00https://www.sec.gov/Archives/edgar/data/1640455/000164045519000076/0001640455-19-000076-index.htm
2020-08-18Hugh M ColeChief Business OfficerSell744.004.713,504.2461,408.00https://www.sec.gov/Archives/edgar/data/1640455/000164045520000107/0001640455-20-000107-index.htm
2019-02-01Elizabeth TrehuChief Medical OfficerBuy22,250.0061,525.00https://www.sec.gov/Archives/edgar/data/1640455/000164045519000012/0001640455-19-000012-index.htm
2020-09-01Kimberlee C DrapkinCFO and TreasurerSell7,200.008.0658,032.0061,708.00https://www.sec.gov/Archives/edgar/data/1640455/000164045520000114/0001640455-20-000114-index.htm
2020-08-17Hugh M ColeChief Business OfficerSell454.004.862,206.4462,152.00https://www.sec.gov/Archives/edgar/data/1640455/000164045520000107/0001640455-20-000107-index.htm
2020-08-14Hugh M ColeChief Business OfficerSell984.004.644,565.7662,606.00https://www.sec.gov/Archives/edgar/data/1640455/000164045520000107/0001640455-20-000107-index.htm
2020-02-03Hugh M ColeChief Business OfficerBuy30,000.0063,590.00https://www.sec.gov/Archives/edgar/data/1640455/000164045520000021/0001640455-20-000021-index.htm
2020-08-18Kimberlee C DrapkinCFO and TreasurerSell744.004.713,504.2468,908.00https://www.sec.gov/Archives/edgar/data/1640455/000164045520000109/0001640455-20-000109-index.htm
2020-08-17Kimberlee C DrapkinCFO and TreasurerSell454.004.862,206.4469,652.00https://www.sec.gov/Archives/edgar/data/1640455/000164045520000109/0001640455-20-000109-index.htm
2020-08-14Kimberlee C DrapkinCFO and TreasurerSell984.004.644,565.7670,106.00https://www.sec.gov/Archives/edgar/data/1640455/000164045520000109/0001640455-20-000109-index.htm
2020-02-03Kimberlee C DrapkinCFO and TreasurerBuy26,700.0071,090.00https://www.sec.gov/Archives/edgar/data/1640455/000164045520000019/0001640455-20-000019-index.htm
2020-08-14Elizabeth TrehuChief Medical OfficerSell744.004.713,504.2476,633.00https://www.sec.gov/Archives/edgar/data/1640455/000164045520000108/0001640455-20-000108-index.htm
2020-08-17Elizabeth TrehuChief Medical OfficerSell454.004.862,206.4477,377.00https://www.sec.gov/Archives/edgar/data/1640455/000164045520000108/0001640455-20-000108-index.htm
2020-08-14Elizabeth TrehuChief Medical OfficerSell984.004.644,565.7677,831.00https://www.sec.gov/Archives/edgar/data/1640455/000164045520000108/0001640455-20-000108-index.htm
2020-02-03Elizabeth TrehuChief Medical OfficerBuy22,250.0078,815.00https://www.sec.gov/Archives/edgar/data/1640455/000164045520000022/0001640455-20-000022-index.htm
2020-01-07RICHARD /CA/ MURRAYCEO and PresidentSell7,150.007.7855,627.0087,360.00https://www.sec.gov/Archives/edgar/data/1640455/000164045520000004/0001640455-20-000004-index.htm
2019-02-01RICHARD /CA/ MURRAYCEO and PresidentBuy62,510.0094,510.00https://www.sec.gov/Archives/edgar/data/1640455/000164045519000009/0001640455-19-000009-index.htm
2019-12-23RICHARD /CA/ MURRAYCEO and PresidentSell40,000.008.37334,800.0094,510.00https://www.sec.gov/Archives/edgar/data/1640455/000164045519000095/0001640455-19-000095-index.htm